The Filings Report

Rocket Lab

RKLBNasdaqCIK 1819994Industrials / Aerospace & Defensefiscal year ends December26 quarters since 2020

Revenue, Q2 FY2026
$234M
+62.0% on Q2 FY2025
Net income
−$49M
+25.8% on Q2 FY2025
Free cash flow
−$110M
−99.2% on Q2 FY2025
Diluted EPS
$-0.08
+38.5% on Q2 FY2025
Revenue, TTM
$769M
trailing four quarters
Net margin, TTM
-21.5%
net income −$165M
Free cash flow, TTM
−$371M
−$222M less $149M capex
Cash and equivalents
$2.1B
long-term debt $2M, Jun 30, 2026
Shares, 12-month change
+24.8%
598M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$32.7B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 10, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Rocket Lab reported revenue of $234M, +62.0% on Q2 FY2025, and net loss of $49M (+25.8%). Operating margin was −24.6%. Free cash flow, operating cash flow less capital expenditures, was −$110M (−$84M less $26M). Diluted earnings per share were $-0.08.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 10, 2026.

Revenue and net incomeRevenueNet income
−$100M$0$100M$200M$300MQ3'22, Revenue: $63MQ3'22, Net income: −$35MQ3'22Q4'22, Revenue: $52MQ4'22, Net income: −$37MQ4'22Q1'23, Revenue: $55MQ1'23, Net income: −$46MQ1'23Q2'23, Revenue: $62MQ2'23, Net income: −$46MQ2'23Q3'23, Revenue: $68MQ3'23, Net income: −$41MQ3'23Q4'23, Revenue: $60MQ4'23, Net income: −$50MQ4'23Q1'24, Revenue: $93MQ1'24, Net income: −$44MQ1'24Q2'24, Revenue: $106MQ2'24, Net income: −$42MQ2'24Q3'24, Revenue: $105MQ3'24, Net income: −$52MQ3'24Q4'24, Revenue: $132MQ4'24, Net income: −$52MQ4'24Q1'25, Revenue: $123MQ1'25, Net income: −$61MQ1'25Q2'25, Revenue: $144MQ2'25, Net income: −$66MQ2'25Q3'25, Revenue: $155MQ3'25, Net income: −$18MQ3'25Q4'25, Revenue: $180MQ4'25, Net income: −$53MQ4'25Q1'26, Revenue: $200MQ1'26, Net income: −$45MQ1'26Q2'26, Revenue: $234MQ2'26, Net income: −$49MQ2'26−$100M$0$100M$200M$300MQ3'22, Revenue: $63MQ3'22, Net income: −$35MQ4'22, Revenue: $52MQ4'22, Net income: −$37MQ4'22Q1'23, Revenue: $55MQ1'23, Net income: −$46MQ2'23, Revenue: $62MQ2'23, Net income: −$46MQ2'23Q3'23, Revenue: $68MQ3'23, Net income: −$41MQ4'23, Revenue: $60MQ4'23, Net income: −$50MQ4'23Q1'24, Revenue: $93MQ1'24, Net income: −$44MQ2'24, Revenue: $106MQ2'24, Net income: −$42MQ2'24Q3'24, Revenue: $105MQ3'24, Net income: −$52MQ4'24, Revenue: $132MQ4'24, Net income: −$52MQ4'24Q1'25, Revenue: $123MQ1'25, Net income: −$61MQ2'25, Revenue: $144MQ2'25, Net income: −$66MQ2'25Q3'25, Revenue: $155MQ3'25, Net income: −$18MQ4'25, Revenue: $180MQ4'25, Net income: −$53MQ4'25Q1'26, Revenue: $200MQ1'26, Net income: −$45MQ2'26, Revenue: $234MQ2'26, Net income: −$49MQ2'26

Net income losses drawn in red.

Free cash flow
−$150M−$100M−$50M$0$50MQ3'22, Free cash flow: −$31MQ3'22Q4'22, Free cash flow: −$34MQ4'22Q1'23, Free cash flow: −$38MQ1'23Q2'23, Free cash flow: −$17MQ2'23Q3'23, Free cash flow: −$46MQ3'23Q4'23, Free cash flow: −$53MQ4'23Q1'24, Free cash flow: −$22MQ1'24Q2'24, Free cash flow: −$28MQ2'24Q3'24, Free cash flow: −$42MQ3'24Q4'24, Free cash flow: −$24MQ4'24Q1'25, Free cash flow: −$83MQ1'25Q2'25, Free cash flow: −$55MQ2'25Q3'25, Free cash flow: −$69MQ3'25Q4'25, Free cash flow: −$114MQ4'25Q1'26, Free cash flow: −$77MQ1'26Q2'26, Free cash flow: −$110MQ2'26−$150M−$100M−$50M$0$50MQ3'22, Free cash flow: −$31MQ4'22, Free cash flow: −$34MQ4'22Q1'23, Free cash flow: −$38MQ2'23, Free cash flow: −$17MQ2'23Q3'23, Free cash flow: −$46MQ4'23, Free cash flow: −$53MQ4'23Q1'24, Free cash flow: −$22MQ2'24, Free cash flow: −$28MQ2'24Q3'24, Free cash flow: −$42MQ4'24, Free cash flow: −$24MQ4'24Q1'25, Free cash flow: −$83MQ2'25, Free cash flow: −$55MQ2'25Q3'25, Free cash flow: −$69MQ4'25, Free cash flow: −$114MQ4'25Q1'26, Free cash flow: −$77MQ2'26, Free cash flow: −$110MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3BQ3'22, Cash and equivalents: $333MQ3'22, Long-term debt: $99MQ3'22Q4'22, Cash and equivalents: $243MQ4'22, Long-term debt: $100MQ4'22Q1'23, Cash and equivalents: $208MQ1'23, Long-term debt: $101MQ1'23Q2'23, Cash and equivalents: $197MQ2'23, Long-term debt: $0Q2'23Q3'23, Cash and equivalents: $141MQ3'23, Long-term debt: $0Q3'23Q4'23, Cash and equivalents: $163MQ4'23, Long-term debt: $88MQ4'23Q1'24, Cash and equivalents: $366MQ1'24, Long-term debt: $53MQ1'24Q2'24, Cash and equivalents: $341MQ2'24, Long-term debt: $50MQ2'24Q3'24, Cash and equivalents: $292MQ3'24, Long-term debt: $47MQ3'24Q4'24, Cash and equivalents: $271MQ4'24, Long-term debt: $44MQ4'24Q1'25, Cash and equivalents: $303MQ1'25, Long-term debt: $58MQ1'25Q2'25, Cash and equivalents: $564MQ2'25, Long-term debt: $54MQ2'25Q3'25, Cash and equivalents: $808MQ3'25, Long-term debt: $51MQ3'25Q4'25, Cash and equivalents: $829MQ4'25, Long-term debt: $2MQ4'25Q1'26, Cash and equivalents: $1.2BQ1'26, Long-term debt: $2MQ1'26Q2'26, Cash and equivalents: $2.1BQ2'26, Long-term debt: $2MQ2'26$0$1B$2B$3BQ3'22, Cash and equivalents: $333MQ3'22, Long-term debt: $99MQ4'22, Cash and equivalents: $243MQ4'22, Long-term debt: $100MQ4'22Q1'23, Cash and equivalents: $208MQ1'23, Long-term debt: $101MQ2'23, Cash and equivalents: $197MQ2'23, Long-term debt: $0Q2'23Q3'23, Cash and equivalents: $141MQ3'23, Long-term debt: $0Q4'23, Cash and equivalents: $163MQ4'23, Long-term debt: $88MQ4'23Q1'24, Cash and equivalents: $366MQ1'24, Long-term debt: $53MQ2'24, Cash and equivalents: $341MQ2'24, Long-term debt: $50MQ2'24Q3'24, Cash and equivalents: $292MQ3'24, Long-term debt: $47MQ4'24, Cash and equivalents: $271MQ4'24, Long-term debt: $44MQ4'24Q1'25, Cash and equivalents: $303MQ1'25, Long-term debt: $58MQ2'25, Cash and equivalents: $564MQ2'25, Long-term debt: $54MQ2'25Q3'25, Cash and equivalents: $808MQ3'25, Long-term debt: $51MQ4'25, Cash and equivalents: $829MQ4'25, Long-term debt: $2MQ4'25Q1'26, Cash and equivalents: $1.2BQ1'26, Long-term debt: $2MQ2'26, Cash and equivalents: $2.1BQ2'26, Long-term debt: $2MQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

Rocket Lab income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 10, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 12, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue234200180155144123132105+62.0%
Cost of revenue1491241119898879677+52.4%
Gross profit8576685746353728+82.3%
Research and development8281797166554848+24.6%
Selling, general and administrative6052404640394032+49.6%
Operating income(58)(56)(51)(59)(60)(59)(52)(52)+3.6%
Other income (expense)14990(4)(2)01+454.0%
Pretax income(44)(47)(42)(59)(63)(61)(52)(51)+30.8%
Income tax5(2)11(41)3(1)11+81.3%
Net income(49)(45)(53)(18)(66)(61)(52)(52)+25.8%
Diluted EPS ($)(0.08)(0.07)—(0.03)(0.13)(0.12)—(0.10)+38.5%
Diluted shares (millions)630605—529515506—498—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

Rocket Lab balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 10, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 12, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents2,1291,205829808564303271292+277.5%
Short-term investments173178188169124125148150+39.2%
Total current assets2,8961,8001,3661,3161,006725693695+187.8%
Total assets4,1872,8202,3242,2211,5531,2551,1841,153+169.6%
Total current liabilities528402334414376348340269+40.3%
Long-term debt2225154584447−96.8%
Total liabilities695556603940865824802733−19.6%
Stockholders’ equity3,4922,2641,7221,281688431382420+407.2%
Shares outstanding (millions)598579567534479461454500—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

Rocket Lab cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 10, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 12, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow(84)(50)(65)(24)(23)(54)(2)(31)−261.7%
Capital expenditures2627504632292211−18.7%
Free cash flow (CFO − capex)(110)(77)(114)(69)(55)(83)(24)(42)−99.2%
Depreciation and amortization211515129998+139.1%
Share repurchases—————————
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.

Income statement

Rocket Lab income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 7, 2023FY2021ended Dec 31, 2021filed Mar 24, 2022FY2020ended Dec 31, 2020filed Mar 31, 2021
Revenue6024362452116235
Cost of revenue3953201931926447
Gross profit2071165119(2)(12)
Research and development271174119654219
Selling, general and administrative165132110895824
Operating income(229)(190)(178)(135)(102)(55)
Other income (expense)30(1)2(23)0
Pretax income(226)(189)(179)(133)(125)(55)
Income tax(28)143(8)0
Net income(198)(190)(183)(136)(117)(55)
Diluted EPS ($)(0.37)(0.38)(0.38)(0.29)(0.56)(0.73)
Diluted shares (millions)53149648246621075

Balance sheet

Rocket Lab balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 7, 2023FY2021ended Dec 31, 2021filed Mar 24, 2022FY2020ended Dec 31, 2020filed Mar 31, 2021
Cash and equivalents82927116324369153
Short-term investments188148822290—
Total current assets1,36669347766277593
Total assets2,3241,184941989981188
Total current liabilities3343402231639648
Long-term debt24488100970
Total liabilities60380238731628280
Stockholders’ equity1,722382555673698(167)
Shares outstanding (millions)567454489478465—

Cash flow statement

Rocket Lab cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 7, 2023FY2021ended Dec 31, 2021filed Mar 24, 2022FY2020ended Dec 31, 2020filed Mar 31, 2021
Operating cash flow(166)(49)(99)(107)(72)(28)
Capital expenditures1566755422625
Free cash flow (CFO − capex)(322)(116)(154)(149)(97)(53)
Depreciation and amortization44343030119
Share repurchases——————
Dividends paid——————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$27M
25 sales by 5 insiders; officers and directors $27M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$683M
216 sales by 11 insiders; officers and directors $683M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Spice Adam C.Chief Financial Officeroption exercise140,157$1.09$153K1MOct 2, 2026
Oct 1, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-139,669$70.28$3M1MOct 2, 2026
Oct 1, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-185,288$70.89$6M1MOct 2, 2026
Oct 1, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-115,200$71.79$1M1MOct 2, 2026
Sep 2, 2026Spice Adam C.Chief Financial Officeroption exercise140,157$1.09$153K1MSep 4, 2026
Sep 2, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-167,257$62.26$4M1MSep 4, 2026
Sep 2, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-172,900$62.97$5M1MSep 4, 2026
Aug 31, 2026Saintil MerlineDirectorgift261,903$0.00—2,482Sep 2, 2026
Aug 31, 2026Saintil MerlineDirectorgiftindirect261,903$0.00—261,903Sep 2, 2026
Aug 27, 2026Klein FrankChief Operations Officeropen-market sale10b5-115,300$66.25$1M945,995Aug 28, 2026
Aug 27, 2026Klein FrankChief Operations Officeropen-market sale10b5-119,800$66.86$1M926,195Aug 28, 2026
Aug 27, 2026Klein FrankChief Operations Officeropen-market sale10b5-1458$67.54$31K925,737Aug 28, 2026
Aug 27, 2026Kampani ArjunSVP & General Counselopen-market sale10b5-14,600$66.50$306K252,351Aug 28, 2026
Aug 27, 2026Kampani ArjunSVP & General Counselopen-market sale10b5-11,434$67.16$96K250,917Aug 28, 2026
Aug 24, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-18,952$69.53$622K1MAug 26, 2026
Aug 24, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-1290$70.20$20K1MAug 26, 2026
Aug 24, 2026Spice Adam C.Chief Financial Officeropen-market sale10b5-1435$71.17$31K1MAug 26, 2026
Aug 24, 2026Ricupati AgostinoVP Corp Controller & CAOopen-market sale619$69.53$43K26,913Aug 26, 2026
Aug 24, 2026Ricupati AgostinoVP Corp Controller & CAOopen-market sale20$70.20$1K26,893Aug 26, 2026
Aug 24, 2026Ricupati AgostinoVP Corp Controller & CAOopen-market sale30$71.17$2K26,863Aug 26, 2026
Aug 24, 2026Klein FrankChief Operations Officeropen-market sale10b5-142,270$69.53$3M964,717Aug 26, 2026
Aug 24, 2026Klein FrankChief Operations Officeropen-market sale10b5-11,368$70.20$96K963,349Aug 26, 2026
Aug 24, 2026Klein FrankChief Operations Officeropen-market sale10b5-12,054$71.17$146K961,295Aug 26, 2026
Aug 24, 2026Kampani ArjunSVP & General Counselopen-market sale10b5-17,173$69.53$499K257,532Aug 26, 2026
Aug 24, 2026Kampani ArjunSVP & General Counselopen-market sale10b5-1232$70.20$16K257,300Aug 26, 2026

Full insider history for Rocket Lab, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Rocket Lab Corp, CIK 1819994 on EDGAR
Extract generated
August 28, 2026
Withheld
none
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2021, income tax FY2022
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: not filed
Dividends paid: not filed

The data

The statements on this page as files, generated August 28, 2026.

JSON file
/data/financials/RKLB.json